Neuronetics, Inc.
STIMNeuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
26dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How STIM's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Neuronetics, Inc.'s next FDA catalyst?→
Neuronetics, Inc.'s (STIM) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track STIM biotech catalysts?→
Add STIM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Neuronetics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.